Shengtai Pharmaceut (SGTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,530 | 18,796 | 16,498 | 17,988 | 19,364 |
| Receivables | 16,550 | 16,006 | 15,806 | 20,962 | 10,889 |
| Inventories | 43,198 | 35,845 | 32,084 | 29,458 | 26,501 |
| Other current assets | 11,975 | 5,061 | 6,230 | 5,614 | 3,324 |
| TOTAL | $84,252 | $75,709 | $70,618 | $74,022 | $60,077 |
| Non-Current Assets | |||||
| PPE Net | 82,363 | 83,925 | 81,904 | 81,399 | 82,204 |
| Investments And Advances | 13,150 | 12,845 | 11,972 | 11,704 | 11,208 |
| Intangibles | 3,333 | 3,348 | 3,260 | 3,271 | 3,287 |
| Other Non-Current Assets | 882 | 1,487 | 1,484 | 2,189 | 795 |
| TOTAL | $99,727 | $101,605 | $98,620 | $98,563 | $97,493 |
| Total Assets | $183,979 | $177,314 | $169,238 | $172,585 | $157,569 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 82,606 | 77,491 | 75,833 | 73,779 | 61,217 |
| Accounts payable and accrued liabilities | 14,837 | 13,663 | 10,194 | 7,548 | 10,252 |
| Accrued Expenses | 468 | 560 | 543 | 480 | 471 |
| Other current liabilities | 12,769 | 8,832 | 10,512 | 9,610 | 5,181 |
| TOTAL | $119,695 | $113,332 | $106,828 | $110,251 | $95,399 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $119,695 | $113,332 | $106,828 | $110,251 | $95,399 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,585 | 9,585 | 9,585 | 9,585 | 9,585 |
| Common Shares | 10 | 10 | 10 | 10 | 10 |
| Retained earnings | 27,545 | 27,457 | 27,229 | 27,064 | 26,934 |
| Other shareholders' equity | 14,785 | 14,570 | 13,226 | 13,316 | 13,309 |
| TOTAL | $64,284 | $63,982 | $62,410 | $62,335 | $62,170 |
| Total Liabilities And Equity | $183,979 | $177,314 | $169,238 | $172,585 | $157,569 |